Why is Novo Nordisk cutting GLP‑1 drug prices? #health

Why is Novo Nordisk cutting GLP‑1 drug prices? #health

Rationale behind the price cuts and what it could mean Novo Nordisk announced plans to reduce U.S. list prices for its GLP‑1 diabetes and obesity medicines by up to 50% beginning in 2027. The company frames the move as a way to expand access to treatments tha…

Rationale behind the price cuts and what it could mean Novo Nordisk announced plans to reduce U.S. list prices for its GLP1 diabetes and obesity medicines by up to 50% beginning in 2027. The company… [+1670 chars]
Why is Novo Nordisk cutting GLP‑1 drug prices? #health - FHMnews